Interna, Daiichi Sankyo Partner on Drug Delivery Tech
PETACH TIKVA, Israel, April 16, 2026 Interna Therapeutics has announced a strategic research collaboration with Daiichi Sankyo to advance...
Preclinical Research
Advertisement
Insilico Medicine Advances ISM6200 for Cancer Therapy
HONG KONG | April 10, 2026 Insilico Medicine has announced the nomination of ISM6200, a potential best-in-class selective NR3C1...
Insilico, Lilly Sign $2.75B AI Drug Discovery Deal
Hong Kong | March 30, 2026 Strategic AI Collaboration to Accelerate Drug Discovery Insilico Medicine has announced a major...
AI Drug Discovery Deal Expands CNS Pipeline Value
Hong Kong | March 30, 2026 AI Collaboration Accelerates CNS Drug Discovery Insilico Medicine and Tenacia Biotechnology have announced...
Junevity Study Reveals Single-Target Control of Cellular Aging
BOSTON, Massachusetts — January 12, 2026 — Junevity has announced the publication of its first peer-reviewed scientific study demonstrating...
Advertisements
NAMSA Acquires Labcorp Device Testing Assets to Expand MedTech
Toledo, Ohio — January 8, 2026 — NAMSA, a global leader in medical device testing, clinical research, and regulatory...
Illinois Grant Fuels Helix 51 Cancer Drug Development
ROCKFORD, Illinois | January 8, 2026 — A Helix 51 incubator company based at RFU (Rockford, IL) has received...
Government contract pursuit advances Halberd TBI nasal-spray program
JACKSON CENTER, Pa., November 3, 2025 — Halberd Corporation, in collaboration with Mississippi State University (MSU), announced continued efforts...
FDA Fast-Tracks Blacksmith’s FG-2101, a Novel Antibiotic Targeting LpxC
SAN DIEGO, California, October 13, 2025 – In a major advancement for antimicrobial innovation, Blacksmith Medicines, Inc. announced that...
Advertisement
